Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma
1. Event-free survival at 2 years was longer in the neoadjuvant-adjuvant group vs the...
Read MoreMar 10, 2023
1. Event-free survival at 2 years was longer in the neoadjuvant-adjuvant group vs the...
Read MoreMar 10, 2023
1. For patients diagnosed with breast cancer liver metastases (BCLM), liver function tests were...
Read MoreMar 1, 2023
1. Low household income is associated with higher 21-gene recurrence scores (score based on gene...
Read MoreFeb 21, 2023
1. In this comparative modeling study, risk model-based lung cancer screening strategies yielded...
Read MoreFeb 15, 2023
1. In this scoping review, it was shown that spirituality allowed patients with breast cancer to...
Read MoreFeb 14, 2023
1. In this noninferiority trial, medial retropharyngeal lymph node (MRLN)-sparing radiotherapy was...
Read MoreFeb 13, 2023
1. The 5-year disease-free survival, overall survival, and recurrence rates were similar in both...
Read MoreFeb 10, 2023
1. For patients with a history of lymphoma or breast cancer, anthracycline use is associated with...
Read MoreFeb 9, 2023
1. After a 24-week treatment period, a significantly greater proportion of patients randomized to...
Read MoreFeb 7, 2023
1. In this prospective cohort study, fecal hemoglobin concentration (f-Hb) was associated with...
Read MoreFeb 2, 2023
1. Patients who received adjuvant S-1 had prolonged overall survival and relapse-free survival...
Read MoreJan 27, 2023
1. In this prospective cohort study, greater consumption of healthful plant-based foods was...
Read MoreJan 24, 2023
1. The proportion of patients receiving serious illness conversations (SICs) was increased in the...
Read MoreJan 24, 2023
1. Using futibatinib to treat patients with FGFR mutated intrahepatic cholangiocarcinoma resulted...
Read MoreJan 18, 2023
1. Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with...
Read MoreJan 18, 2023
1. There was some progression-free survival benefit in adding veliparib to cisplatin in patients...
Read MoreJan 11, 2023
1. Greater early-life body size is not an independent risk factor for colorectal cancer (aside...
Read MoreJan 11, 2023
1. In this randomized controlled trial, the post-test fatigue score was significantly lower in...
Read MoreJan 9, 2023
1. In this randomized controlled trial, religious psychotherapy was associated with significant...
Read MoreJan 9, 2023
1. In patients with KRAS p.G12C mutated pancreatic cancer, 21% had a partial response, and 0% had...
Read More